Addex Therapeutics Ltd. (ADXN)
3.90
-0.15
(-3.70%)
USD |
NASDAQ |
Aug 25, 15:05
Addex Therapeutics Price to Book Value : 0.9487 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 0.9852 |
| August 21, 2026 | 1.202 |
| August 20, 2026 | 1.112 |
| August 19, 2026 | 1.387 |
| August 18, 2026 | 1.387 |
| August 17, 2026 | 1.387 |
| August 14, 2026 | 1.447 |
| August 13, 2026 | 1.447 |
| August 12, 2026 | 1.447 |
| August 11, 2026 | 1.447 |
| August 10, 2026 | 1.447 |
| August 07, 2026 | 1.411 |
| August 06, 2026 | 1.411 |
| August 05, 2026 | 1.384 |
| August 04, 2026 | 1.384 |
| August 03, 2026 | 1.265 |
| July 31, 2026 | 1.265 |
| July 30, 2026 | 1.361 |
| July 29, 2026 | 1.432 |
| July 28, 2026 | 1.432 |
| July 27, 2026 | 1.432 |
| July 24, 2026 | 1.432 |
| July 23, 2026 | 1.432 |
| July 22, 2026 | 1.432 |
| July 21, 2026 | 1.434 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.362 |
| July 17, 2026 | 1.385 |
| July 16, 2026 | 1.445 |
| July 15, 2026 | 1.505 |
| July 14, 2026 | 1.411 |
| July 13, 2026 | 1.389 |
| July 10, 2026 | 1.542 |
| July 09, 2026 | 1.433 |
| July 08, 2026 | 1.433 |
| July 07, 2026 | 1.408 |
| July 06, 2026 | 1.408 |
| July 02, 2026 | 1.408 |
| July 01, 2026 | 1.392 |
| June 30, 2026 | 1.387 |
| June 29, 2026 | 1.460 |
| June 26, 2026 | 1.477 |
| June 25, 2026 | 1.445 |
| June 24, 2026 | 1.460 |
| June 23, 2026 | 1.569 |
| June 22, 2026 | 1.586 |
| June 18, 2026 | 1.508 |
| June 17, 2026 | 1.511 |
| June 16, 2026 | 1.511 |
| June 15, 2026 | 1.460 |
| June 12, 2026 | 1.569 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novartis AG | 7.047 |
| Roche Holding AG | -- |
| Oculis Holding AG | 2.976 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Price to Book Value Related Metrics
| PS Ratio | 26.94 |
| Price | 3.90 |
| Earnings Yield | -238.7% |
| Market Cap | 3.878M |